Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plicamycin maleate vs other chemotherapy for relapsed/refractory aggressive NHL
CTR20160923Phase 3Terminated
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Mithramycin in non-Hodgkin lymphoma (NHL), sponsored by Chia Tai-Tianqing Pharmaceutical Group. Started Feb 2017; status: terminated.
02
Drugs
Mithramycin
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on CTR20160923.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160923.